Answers are grounded in this paper and cite their sources.
Study assessed PPO-inhibitor herbicide resistance in Amaranthus palmeri, indicating evolution of resistance mechanisms.
BACKGROUND: Amaranthus is a highly troublesome weed genera globally. Most cotton, corn, and soybean fields in the US mid-south have Amaranthus palmeri populations resistant to protoporphyrinogen oxidase (PPO)-inhibiting herbicides. We evaluated the persistence of resistance to PPO-inhibiting herbicides in A. palmeri populations from Greene (GRE-A) and Crittenden (CRI-D) counties, Arkansas, collected in 2015 and approximately 8 years later. RESULTS: Fomesafen, the primary selector for resistance to PPO-inhibiting herbicides, was the least effective herbicide in both post- and pre-emergence tests. Soil-applied sulfentrazone was more effective on GRE-A than CRI-D populations. Fomesafen was less effective on CRI-D than GRE-A populations. GRE-A populations were more resistant to foliar-applied PPO-inhibiting herbicides (62-76% control) than CRI-D populations. Resistance to fomesafen in CRI-D increased significantly with time, declining from 91% control in 15-CRI-D to 48% in 22-CRI-D. GRE-A populations harbored high frequencies of ΔG210 and A399 mutations. CRI-D populations predominantly harbored ΔG210 and G128 mutations. Increased resistance to fomesafen was strongly linked to increased frequency of single mutations, primarily ΔG210. Resistance to foliar-applied flumioxazin lacked a clear association with target-site mutations, while resistance to saflufenacil was associated with enrichment of double mutations. CONCLUSIONS: PPO2 mutations remained the primary factor conferring resistance to PPO-inhibiting herbicides over 8 years, underscoring their evolutionary advantage in maintaining A. palmeri resistance. The weak relationship between resistance level and mutation frequency indicates enrichment of additional resistance-conferring mechanisms. Stronger, contemporary PPO-inhibitor herbicides are still effective on resistant populations, but rare escapes carry nontarget-site resistance (NTSR) mechanisms which should be mitigated with other management tools.
No takes yet. Share an insight, caveat, or question.
Dhaka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: